Clinical Trial Update: Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update reports results for a combination of liposomal irinotecan, fluorouracil, leucovorin, and rucaparib in patients with metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Carcinoma
• Colorectal Carcinoma
• Gastroesophageal Junction Adenocarcinoma
• Pancreatic Adenocarcinoma

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Leucovorin calcium (calcium folinate)
• Onivyde (irinotecan hydrochloride liposome injection)
• RUBRACA (RUCAPARIB)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Metastatic Biliary Tract Carcinoma, Metastatic Colorectal Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-05-17